[Treatment of high blood cholesterol in patients with coronary heart disease]

Nihon Rinsho. 2003 Apr:61 Suppl 4:675-81.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anion Exchange Resins / pharmacology
  • Anion Exchange Resins / therapeutic use
  • Cholesterol, LDL / metabolism
  • Cholestyramine Resin / pharmacology
  • Cholestyramine Resin / therapeutic use
  • Clinical Trials as Topic
  • Coronary Disease / etiology*
  • Coronary Disease / prevention & control
  • Fenofibrate / pharmacology
  • Fenofibrate / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / complications*
  • Hypercholesterolemia / drug therapy*
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use*
  • Primary Prevention
  • Probucol / pharmacology
  • Probucol / therapeutic use
  • Receptors, LDL / metabolism
  • Risk Factors

Substances

  • Anion Exchange Resins
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Receptors, LDL
  • Cholestyramine Resin
  • Probucol
  • Fenofibrate